Enorama Pharma AB (publ) (STO:ERMA)
Sweden · Delayed Price · Currency is SEK 0.7060
+0.0060 (0.86%)
Sep 4, 2026, 9:22 AM CET
Enorama Pharma AB Employees
Enorama Pharma AB had 4 employees as of December 31, 2025. The number of employees decreased by 1 or -20.00% compared to the previous year.
Employees
4
Change (1Y)
-1
Growth (1Y)
-20.00%
Revenue / Employee
361.75K SEK
Profits / Employee
-14.92M SEK
Market Cap
52.21M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | -1 | -20.00% |
| Dec 31, 2024 | 5 | 0 | - |
| Dec 31, 2023 | 5 | -4 | -44.44% |
| Dec 31, 2022 | 9 | -1 | -10.00% |
| Dec 31, 2021 | 10 | 3 | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EQL Pharma AB | 65 |
| Orexo AB | 61 |
| Enzymatica AB | 18 |
| Cinclus Pharma Holding AB | 17 |
| Nanexa AB | 17 |
| Newbury Pharmaceuticals AB | 7 |
| Moberg Pharma AB | 5 |
| Vivesto AB | 4 |
Enorama Pharma AB News
- 16 days ago - Enorama Records Lower Q2 Loss With Pending PMTA Case; Stock Down - Nasdaq
- 16 days ago - Enorama Pharma AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Enorama Pharma AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Enorama Pharma AB Quarterly report: Q4 2025 - Filings
- 5 months ago - Enorama Pharma AB Annual report: Q4 2025 - Filings
- 9 months ago - Enorama Pharma AB Quarterly report: Q3 2025 - Filings